• ML133 HCl: Unveiling New Dimensions in Kir2.1 Channel Inh...

  2025-10-22

  Explore how ML133 HCl, a selective potassium channel inhibitor, is revolutionizing pulmonary artery smooth muscle cell proliferation research. This article offers an advanced analysis of Kir2.1 channel blockade, elucidating mechanisms and applications beyond current literature.

• ML133 HCl: Selective Kir2.1 Channel Blocker in Cardiovasc...

  2025-10-21

  ML133 HCl is a highly selective potassium channel inhibitor that delivers unmatched precision for studying Kir2.1-mediated cellular mechanisms. Its optimized solubility profile and proven efficacy in pulmonary artery smooth muscle cell proliferation research make it indispensable for cardiovascular disease modeling and translational ion channel studies.

92 records 7/7 page Previous First page 上5页 67